PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Ann: Paradigm to Present at Evercore ISI HealthCONx Conference, page-208

  1. 1,314 Posts.
    lightbulb Created with Sketch. 263
    Yep, and Scott did really well alleviating the concerns of investors by telling us that he bought some PAR shares for his infant son. That's nice. Hope the timeline isn't worse than we're already thinking...
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.